23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
04/19 16:25 (美東)
23andMe | 8-K:23andMe宣佈首席執行官有意尋求潛在的私有化
04/18 08:11 (美東)
23andMe | SC 13D/A:超過5%持股股東披露文件(修正)-Anne Wojcicki(25.8%),ABeeC 2.0, LLC(23.9%)等
04/17 18:25 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
04/05 16:20 (美東)
23andMe | 8-K:23andMe首席運營官Kathy Hibbs退休,Guy Chayoun接任
03/29 12:47 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
03/22 19:23 (美東)
23andMe | S-8:員工福利計劃證券登記
03/22 17:09 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
03/11 16:13 (美東)
23andMe | 144:擬議出售證券
03/07 16:27 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
02/23 17:16 (美東)
23andMe | 4:持股變動聲明-高管 Richards William G
02/21 16:45 (美東)
23andMe | 4:持股變動聲明-高管 Selsavage Joseph Anthony
02/21 16:44 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
02/21 16:41 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
02/16 16:52 (美東)
23andMe | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(7.24%)
02/13 18:17 (美東)
23andMe | SC 13D/A:超過5%持股股東披露文件(修正)-GSK plc(11.2%)
02/09 16:25 (美東)
23andMe | 10-Q:季度報表
02/07 16:14 (美東)
23andMe | 8-K:23andMe公佈2024財年第三季度財務業績
02/07 16:07 (美東)
23andMe | 8-K:23andMe宣佈FDA批准其針對ULBP6的雙機制抗體23ME-01473的臨床申請
01/31 07:51 (美東)
23andMe | 4:持股變動聲明-高管 HIBBS KATHY L
01/26 20:26 (美東)
暫無數據
暫無數據